Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vassiliki Saloura

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Cancers|October 23, 2021
Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck CancerKyunghee Burkitt, Vassiliki Saloura
Epigenomics|July 14, 2025
Bifaceted functions of histone methyltransferasesJawad Akhtar, Vassiliki Saloura
Genes|November 11, 2022
Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell CarcinomaMadhavi Murali, Vassiliki Saloura
Hematology (Amsterdam, Netherlands)|September 25, 2010
Lenalidomide: a synthetic compound with an evolving role in cancer managementVassiliki Saloura, Petros D Grivas
The Lancet. Oncology|January 19, 2015
EGFR-based bioradiotherapy in SCCHNVassiliki Saloura, Everett E Vokes
Epigenetics|November 4, 2017
Critical roles of protein methyltransferases and demethylases in the regulation of embryonic stem cell fateTheodore Vougiouklakis, Yusuke Nakamura, Vassiliki Saloura
Nature Reviews. Cancer|January 24, 2015
Critical roles of non-histone protein lysine methylation in human tumorigenesisRyuji Hamamoto, Vassiliki Saloura, Yusuke Nakamura
Oncotarget|January 20, 2018
Protein methyltransferases and demethylases dictate CD8+ T-cell exclusion in squamous cell carcinoma of the head and neckTheodore Vougiouklakis, Riyue Bao, Yusuke Nakamura, et al.
Epigenomics|May 6, 2015
The NSD family of protein methyltransferases in human cancerTheodore Vougiouklakis, Ryuji Hamamoto, Yusuke Nakamura, et al.
Clinical Epigenetics|February 27, 2021
SMYD3: a regulator of epigenetic and signaling pathways in cancerBenjamin J Bernard, Nupur Nigam, Kyunghee Burkitt, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Cancers|October 23, 2021
Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck CancerKyunghee Burkitt, Vassiliki Saloura
Epigenomics|July 14, 2025
Bifaceted functions of histone methyltransferasesJawad Akhtar, Vassiliki Saloura
Genes|November 11, 2022
Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell CarcinomaMadhavi Murali, Vassiliki Saloura
Hematology (Amsterdam, Netherlands)|September 25, 2010
Lenalidomide: a synthetic compound with an evolving role in cancer managementVassiliki Saloura, Petros D Grivas
The Lancet. Oncology|January 19, 2015
EGFR-based bioradiotherapy in SCCHNVassiliki Saloura, Everett E Vokes
Epigenetics|November 4, 2017
Critical roles of protein methyltransferases and demethylases in the regulation of embryonic stem cell fateTheodore Vougiouklakis, Yusuke Nakamura, Vassiliki Saloura
Nature Reviews. Cancer|January 24, 2015
Critical roles of non-histone protein lysine methylation in human tumorigenesisRyuji Hamamoto, Vassiliki Saloura, Yusuke Nakamura
Oncotarget|January 20, 2018
Protein methyltransferases and demethylases dictate CD8+ T-cell exclusion in squamous cell carcinoma of the head and neckTheodore Vougiouklakis, Riyue Bao, Yusuke Nakamura, et al.
Epigenomics|May 6, 2015
The NSD family of protein methyltransferases in human cancerTheodore Vougiouklakis, Ryuji Hamamoto, Yusuke Nakamura, et al.
Clinical Epigenetics|February 27, 2021
SMYD3: a regulator of epigenetic and signaling pathways in cancerBenjamin J Bernard, Nupur Nigam, Kyunghee Burkitt, et al.
Pageof 6